Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT – Get Free Report) was the recipient of a significant decrease in short interest during the month of August. As of August 31st, there was short interest totaling 238 shares, a decrease of 40.5% from the August 15th total of 400 shares. Based on an average daily trading volume, of 2,022 shares, the short-interest ratio is currently 0.1 days. Approximately 0.1% of the company’s stock are short sold.
Innovator IBD Breakout Opportunities ETF Price Performance
BOUT traded up $0.44 during midday trading on Thursday, hitting $43.38. 2,669 shares of the company’s stock traded hands, compared to its average volume of 3,723. The company has a market cap of $43.34 million, a PE ratio of 28.69 and a beta of 1.02. The stock’s fifty day simple moving average is $45.37 and its 200-day simple moving average is $44.46. Innovator IBD Breakout Opportunities ETF has a one year low of $35.05 and a one year high of $49.41.
Institutional Inflows and Outflows
An institutional investor recently raised its stake in Innovator IBD Breakout Opportunities ETF stock. Comprehensive Wealth Management LLC raised its stake in shares of Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT – Free Report) by 122.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,403 shares of the company’s stock after buying an additional 12,859 shares during the period. Comprehensive Wealth Management LLC owned 6.69% of Innovator IBD Breakout Opportunities ETF worth $850,000 at the end of the most recent quarter.
About Innovator IBD Breakout Opportunities ETF
The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.
See Also
- Five stocks we like better than Innovator IBD Breakout Opportunities ETF
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for Innovator IBD Breakout Opportunities ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD Breakout Opportunities ETF and related companies with MarketBeat.com's FREE daily email newsletter.
